Providing specialist services for the improved prediction of drug safety and efficacy using human tissue based models of drug activity. REPROCELL’s Centre for Predictive Drug Discovery was officially opened by the First Minister, Nicola Sturgeon MSP on 9th August 2017. The Centre’s work continues over 15 years of successful delivery of preclinical contract research services by Biopta Ltd, a Glasgow company founded in 2002 and...
Innovation & “a very different way of thinking” is at the core of NovaBiotics & the reason for our success; combating antimicrobial resistance (AMR) by developing first-in-class new medicines for medically unmet, socioeconomically significant infections We specialise in unconventional ‘Smart Immunology’ based approaches to tackling infection and in doing so have engineered antifungal and antibacterial drug candidates with the potential to revolutionise the anti-infective industry....
The new £44 million facility at GSK Montrose will provide ingredients for over 400 million vaccinations a year. Significant investment in recent years re-affirms GSK’s belief that Scotland is an excellent base to manufacture and export to global markets. Built at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that...